|
|
||||||||
1From the Program in Genomics and the 2Department of Neurology, Childrens Hospital, Boston, Massachusetts; the 3Department of Neurology and 4Program in Neuroscience, Harvard Medical School, Boston, Massachusetts; the 5Departments of Ophthalmology and 6Neurology, Jules Stein Eye Institute, and the 7Bioengineering and 8Neuroscience Interdepartmental Programs, University of California, Los Angeles, California.
PURPOSE. The genetic bases of Duanes retraction syndrome (DRS) were investigated to determine its molecular etiologies. In prior studies, the transcription factors SALL4 and HOXA1 were identified as the genes mutated in DRS with radial anomalies, and in DRS with deafness, vascular anomalies, and cognitive deficits, respectively. Less is known, however, about the genetic etiology of DRS when it occurs in isolation, and only one genetic locus for isolated DRS, the DURS2 locus on chromosome 2, has been mapped to date. Toward the goal of identifying the DURS2 gene, two pedigrees have been ascertained that segregate DRS as a dominant trait.
METHODS. Members of two large dominant DRS pedigrees were enrolled in an ongoing study of the genetic basis of the congenital cranial dysinnervation disorders, and linkage analysis was conducted to determine whether their DRS phenotype maps to the DURS2 locus.
RESULTS. By haplotype analysis, the DRS phenotype in each family cosegregates with markers spanning the DURS2 region. Linkage analysis reveals maximum lod scores >2, establishing that the DRS phenotype in these two pedigrees maps to the DURS2 locus.
CONCLUSIONS. These two pedigrees double the published pedigrees known to map to the DURS2 locus and can thus contribute toward the search for the DURS2 gene. The affected members represent a genetically defined population of DURS2-linked DRS individuals, and hence studies of their clinical and structural features can enhance understanding of the DURS2 phenotype, as described in the companion paper.
This article has been cited by other articles:
![]() |
N. Miyake, J. Chilton, M. Psatha, L. Cheng, C. Andrews, W.-M. Chan, K. Law, M. Crosier, S. Lindsay, M. Cheung, et al. Human CHN1 Mutations Hyperactivate {alpha}2-Chimaerin and Cause Duane's Retraction Syndrome Science, August 8, 2008; 321(5890): 839 - 843. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Demer, R. A. Clark, K. H. Lim, and E. C. Engle Magnetic Resonance Imaging of Innervational and Extraocular Muscle Abnormalities in Duane-Radial Ray Syndrome Invest. Ophthalmol. Vis. Sci., December 1, 2007; 48(12): 5505 - 5511. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Bosley, M. A. Salih, I. A. Alorainy, D. T. Oystreck, M. Nester, K. K. Abu-Amero, M. A. Tischfield, and E. C. Engle Clinical characterization of the HOXA1 syndrome BSAS variant Neurology, September 18, 2007; 69(12): 1245 - 1253. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Demer, R. A. Clark, K.-H. Lim, and E. C. Engle Magnetic Resonance Imaging Evidence for Widespread Orbital Dysinnervation in Dominant Duane's Retraction Syndrome Linked to the DURS2 Locus Invest. Ophthalmol. Vis. Sci., January 1, 2007; 48(1): 194 - 202. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |